Ignite Creation Date:
2025-12-24 @ 5:03 PM
Ignite Modification Date:
2026-05-24 @ 3:45 AM
Study NCT ID:
NCT02109250
Status:
COMPLETED
Last Update Posted:
2017-05-02
First Post:
2014-03-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CAPRELSA® REGISTRY: a Belgian Registry to Evaluate the Use of Vandetanib (Caprelsa®) in Current Clinical Practice
Sponsor:
Genzyme, a Sanofi Company
Organization: